Fairvalue-Calculator Fairvalue-Calculator
EN DE

AFT Pharmaceuticals Limited (AFP) Fair Value & Analysis

Healthcare · AU · Market cap A$341M

PriceA$3.01
Fair ValueA$2.32
Upside-22.9%
Quality96/100
Evidence: High Range A$1.20 – A$3.89

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

AFT Pharmaceuticals Limited (AFP) currently trades at A$3.01, while our model-based Fair Value estimate is A$2.32 — implying the stock looks roughly 22.9% overvalued today. We read business quality at 96/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers proprietary and in-licensed products, including patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, natural health, pain management, skin care, sleeping aids, supplements, and other products. It has a research and development collaboration with Hyloris Pharmaceuticals SA for the development of the Maxigesic IV product. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -78%

Frequently asked questions

Is AFT Pharmaceuticals Limited (AFP) undervalued?
As of Jun 24, 2026, our model estimates a fair value of A$2.32 versus a price of A$3.01 — about −23% (overvalued). Model-based estimate, not financial advice.
What is the fair value of AFP?
Our 21-model fair value for AFT Pharmaceuticals Limited is A$2.32 (as of Jun 24, 2026), built from audited fundamentals. The current price is A$3.01.
What is the quality score of AFP?
AFT Pharmaceuticals Limited has a Quality Score of 96/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.